Skip to content

How does a ‘human rights based approach’ work out on the ground? Lessons from South Africa

Emerging epidemic of transmitted HIV drug resistance in low- and middle-income countries, with highest burden seen in MSM

Bedaquiline as part of tailored therapy for MDR- and XDR-TB achieves impressive culture conversion rates

AbbVie 3D HCV regimen well-tolerated in PEARL trials

HIV care cascade at Kaiser Permanente varies by sex and age

Behavioural and financial incentives may improve HIV treatment outcomes

NNRTIs and protease inhibitors both good for first ART, channelling affects choices

Infants in southern Africa start antiretroviral therapy late with advanced disease

No to treating our way out of the epidemic, say South African experts